科华智慧（深圳）创新药物研发有限公司-天然产物化合物库-创新药物研发-波谱智能解析-化合物冷冻电镜结构解析

天然产物数据库

您可快速检索70万⁺天然产物信息

检索最多: 白僵菌素大品种冬虫夏草人参三七党参大戟决明半夏丁香

CAS No.	英文名/中文名/SMILES	分子式	分子量
-	(3R,5R,6R,7S,24S,28S,39R)-6,37,39-trihydroxy-39-(hydroxymethyl)-5-(1H-indol-3-ylmethoxymethyl)-34-methoxy-2,4,8-trioxa-19-azaoctacyclo[20.13.2.13,7.116,19.012,17.023,31.024,28.032,36]nonatriaconta-1(35),12(17),13,15,22,31,33,36-octaen-9-yne-21,38-dione - COC1=CC2=C3CC[C@@H]4CCC[C@@H]4C3=C5C(=O)CN6CC7=C(CC#CO[C@H]8[C@@H]([C@H](O[C@@H]([C@]8(CO)O)OC(=C1)C2=C5O)COCC9=CNC1=CC=CC=C19)O)C=CC=C7C6=O	C₄₇H₄₆N₂O₁₁	814.9
-	(2S,3S,4R,5R,6R)-6-[[(3R,4aS,6aR,6bS,8aS,12aR,14aR,14bR)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid - C[C@]12CC[C@H](C([C@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O[C@H]7[C@@H]([C@H]([C@@H](O7)CO)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O	C₄₇H₇₄O₁₈	927.1
-	(1R,2R,3'S,6S,7R,10S,12S,13S,14R,16S,19R,20S)-13-[(1S,3R)-3-benzylcyclohexyl]-12-hydroxy-19-[2-[[(1S,3S,4R,5R,8S,10R,11R)-5-hydroxy-13,15-diazatetracyclo[8.7.0.03,8.011,15]heptadec-16-en-4-yl]methyl]furan-3-yl]-3'-(hydroxymethyl)-9,9,20-trimethylspiro[4,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docosane-6,1'-cyclopentane]-5,11,17-trione - C[C@@]12CC[C@@H]3[C@@]45COC(=O)[C@@]6([C@@H]4OC([C@H]5C(=O)[C@H]([C@]3([C@@]17[C@H](O7)C(=O)O[C@H]2C8=C(OC=C8)C[C@H]9[C@@H](CC[C@@H]1[C@@H]9C[C@H]2C=CN3CNC[C@H]3[C@@H]2C1)O)[C@H]1CCC[C@H](C1)CC1=CC=CC=C1)O)(C)C)CC[C@@H](C6)CO	C₅₉H₇₆N₂O₁₁	989.2
-	2-[(2R,3S,3'R,7'R,33S)-11-ethyl-33-(hydroxymethyl)-24-(4-hydroxyphenyl)-28-[(E,3R)-3-hydroxy-5-phenylpent-4-enoxy]-29-methoxy-26-oxospiro[23,31-dioxa-5,8,10-triazaheptacyclo[33.2.2.114,18.03,8.09,13.021,30.022,27]tetraconta-1(37),9(13),11,14,16,18(40),21,24,27,29,35,38-dodecaene-2,5'-pentacyclo[11.8.0.02,10.03,7.015,20]henicosa-1(21),2(10),8,11,13,15,17,19-octaene]-36-yl]guanidine - CCC1=CC2=C(N1)N3CCNC[C@@H]3[C@@]4(C[C@@H]5C=CC6=C([C@@H]5C4)C7=CC8=CC=CC=C8C=C7C=C6)C9=CC(=C(C[C@H](COC1=C(C(=C3C(=O)C=C(OC3=C1CCC1=CC2=CC=C1)C1=CC=C(C=C1)O)OCC[C@H](/C=C/C1=CC=CC=C1)O)OC)CO)C=C9)N=C(N)N	C₇₇H₇₆N₆O₈	1213.5
-	(2R,3R,4S,5R,6R)-2-[(2R,3S,4R,5R,6S)-6-[(2R,3R,4S,5R,6R)-2-[(1R,2R,4R,5'R,6R,7S,8S,9S,12S,13R,15R,16R,18S,19R)-15,19-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol - C[C@@H]1CC[C@@]2([C@H]([C@@H]3[C@H](O2)C[C@H]4[C@@]3(CC[C@H]5[C@H]4C[C@H]([C@@H]6[C@@]5(C[C@H]([C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O[C@@H]9[C@@H]([C@H]([C@H]([C@H](O9)CO)O)O)O)O)O)O)O)C)O)C)C)OC1	C₄₅H₇₄O₂₀	935.1
-	(1R,2S,5R,6S,8R,14S,17S,18R,19S,20S,21S,32S)-25-[(1S)-7-cyclohexyl-5-(oxan-4-yl)-2-oxo-3,4-dihydro-1H-naphthalen-1-yl]-6-cyclopentyl-32-[(2R)-2-[(2R)-3,3-dimethyloxiran-2-yl]-2-hydroxyethyl]-20-hydroxy-1,2,6,18,32-pentamethyl-12,23,27-triazadecacyclo[19.14.1.114,17.123,26.02,19.05,18.08,17.09,13.033,36.029,37]octatriaconta-9(13),10,24,26(37),28,33(36)-hexaene-7,34-dione - C[C@]1(CCC2=CNC3=C2N(C[C@H]4[C@H]([C@H]5[C@](CC[C@@H]6[C@]5([C@@]78CC[C@@H](C7)C9=C([C@@H]8C(=O)[C@@]6(C)C2CCCC2)C=CN9)C)([C@@]2(C4=C1C(=O)C2)C)C)O)C=C3[C@H]1C(=O)CCC2=C(C=C(C=C12)C1CCCCC1)C1CCOCC1)C[C@H]([C@@H]1C(O1)(C)C)O	C₇₂H₉₃N₃O₇	1112.5
-	1-O-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 16-O-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate - C/C(=C\C=C\C=C(\C=C\C=C(\C(=O)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)/C)/C)/C=C/C=C(/C(=O)O[C@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO)\C	C₄₄H₆₄O₂₄	977.0
-	1-[2-[(1R,2S,3aS,4S,7S,8aS)-4-cyclohexyl-1,2,4-trihydroxy-7-[3-(1H-indol-2-yl)prop-1-en-2-yl]-2,3,3a,5,6,7,8,8a-octahydroazulen-1-yl]ethyl]-3-(3-hydroxypropyl)-2-methylguanidine - CN=C(NCCCO)NCC[C@]1([C@H]2C[C@H](CC[C@@]([C@H]2C[C@@H]1O)(C3CCCCC3)O)C(=C)CC4=CC5=CC=CC=C5N4)O	C₃₄H₅₂N₄O₄	580.8
-	[(3S,5S,10S,13R,14R,17R)-17-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate - C[C@H](C/C=C/C(C)(C)OC)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@H]4[C@@]3(CC[C@@H](C4(C)C)OC(=O)C)C)C)C	C₃₃H₅₄O₃	498.8
-	(2S,4aS,6S,6aR,6aS,6bR,8aS,9R,10S,11R,12R,12aR,14bS)-11-hydroxy-2,9-bis(hydroxymethyl)-12-[[(2R,3R)-2-[4-(1H-imidazol-5-yl)piperidin-4-yl]-5-oxopyrrolidin-3-yl]methyl]-2,6a,6b,9,12a-pentamethyl-6-pentyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid - CCCCC[C@H]1C[C@]2(CC[C@](C[C@H]2C3=CC[C@H]4[C@]([C@]13C)(CC[C@H]5[C@@]4([C@H]([C@H]([C@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)O)C[C@@H]7CC(=O)N[C@H]7C8(CCNCC8)C9=CN=CN9)C)C)(C)CO)C(=O)O	C₅₃H₈₄N₄O₁₁	953.3